New treatment to overpower drug resistance in ovarian cancer

New research from the Centenary Institute finds a new death pathway that can break resistance

2010-11-16

(Press-News.org) Drug resistance is a major obstacle in curing ovarian cancer but new research from the Centenary Institute has discovered a treatment that kills ovarian cancer cells in a new way that can break the resistance mechanism. Published today in Autophagy, the researchers found the drug (FTY720) had a potent effect in human ovarian cancer cells, even in those resistant to cisplatin, the most commonly used chemotherapeutic drug currently available for the treatment of ovarian cancer.

Centenary Institute Signal Transduction Head Associate Professor Pu Xia described the findings as a breakthrough in ovarian cancer treatment because, FTY720 kills ovarian cancer cells through a unique way different to the current anti-cancer drugs. Current treatments, such as cisplatin, kill ovarian cancer cells through a way of programming cell death known as apoptosis but this is often reversible or demolished by cancer cells. However, FTY720 kills cells through an irreversible process known as necrosis so the cancer cells cannot resist, repair and relapse.

Each year, around 800 Australian women die from ovarian cancer1, and ovarian cancer remains the leading cause of death in women with gynaecological malignancies over the world.

Dr Xia said: "One of the major reasons for such a poor outcome of ovarian cancer is that the cancer cells have an ability to resist the current chemotherapeutic drugs through a protective shield, which occurs naturally or as a response to the treatment, and this survives the cancer from the treatment. Such a protective shield, uncovered by the findings from the Xia laboratory, is built, at least partially, on a catabolic process, called autophagy, by which cells eat their own non-vital components for survival under stress conditions such as starvation or chemotherapy. Remarkably, despite this survival process being activated by ovarian cancer cells during the treatment, FTY720 is still capable of killing them effectively.

While this research is a major first step toward developing a more effective treatment for ovarian cancer, the researchers claim more pre-clinical and clinical trials are needed before the drug might be used in women with ovarian cancer. However, the researchers are optimistic that the treatment would be available as a new chemotherapeutic agent within the next several years, because this drug has been approved by the US Food and Drug Administration (FDA) for use in the treatment of multiple sclerosis and is also used in multiple clinical trials for the prevention of organ transplant rejection and the treatment of various autoimmune diseases. Recent studies have also shown anti-tumour efficacy in several types of cancers but this is the first time it has been studied for the treatment of ovarian cancer.

INFORMATION: This research was made possible by a Research Fellowship from the Cancer Institute New South Wales to Associate Professor Xia. The project also received support from the National Health and Medical Research Council and Science and Technology Council of Shanghai Municipality.

1. Ovarian Cancer Australia.

Media Contact: Tanya Sarina, Communications Manager at the Centenary Institute
p: 02 9565 6228 m: 0431 029 215 e: t.sarina@centenary.org.au

About the Centenary Institute: The Centenary Institute is an independent medical research institute, affiliated with Royal Prince Alfred Hospital and the University of Sydney. Our blend of highly skilled staff and state-of-the art equipment and facilities has allowed us to become world leaders in three critical areas of medical research – cancer, cardiovascular disease and infectious diseases. For more information, visit www.centenary.org.au

ELSE PRESS RELEASES FROM THIS DATE:

Origin of cells associated with nerve repair discovered

2010-11-16

Scientists have discovered the origin of a unique type of cell known for its ability to support regeneration in the central nervous system. Their findings, published this week in the journal Proceedings of the National Academy of Sciences USA (PNAS), raise the possibility of obtaining a more reliable source of these cells for use in cell transplantation therapy for spinal cord injuries. Olfactory ensheathing cells (OECs), as the name suggests, ensheath and protect the nerve fibres in the olfactory nerve, which transmit olfactory (smell) information to the brain from ...

'Space-time cloak' to conceal events revealed in new study

2010-11-16

The study, by researchers from Imperial College London, involves a new class of materials called metamaterials, which can be artificially engineered to distort light or sound waves. With conventional materials, light typically travels along a straight line, but with metamaterials, scientists can exploit a wealth of additional flexibility to create undetectable blind spots. By deflecting certain parts of the electromagnetic spectrum, an image can be altered or made to look like it has disappeared. Previously, a team led by Professor Sir John Pendry at Imperial College ...

Heavy smoking during pregnancy linked to kids becoming repeat offenders as adults

2010-11-16

Mums who smoke heavily while pregnant run the risk of having kids who grow up to become repeat criminal offenders, suggests research published online in the Journal of Epidemiology and Community Health. The findings held true, even after taking account of a comprehensive range of family and social factors, such as mental ill health and deprivation, which are likely to influence behaviours, the research showed. The authors base their findings on just under 4000 adults aged between 33 and 40, who were part of the Rhode Island cohort of the Collaborative Perinatal Project. ...

Passive smokers at increased risk of hearing loss

2010-11-16

Non-smokers who regularly breathe in others' tobacco smoke are at increased risk of some degree of hearing loss, reveals research published online in Tobacco Control. Previous research indicates that former and current smokers are more likely to lose some of their full range of hearing, but it's not been known whether passive smokers are also prone to this. The authors drew on 1999-2004 data from the National Health and Nutrition Examination Survey (NHANES), a yearly household survey combined with a physical examination of a representative sample of the US population. ...

US scientists significantly more likely to publish fake research

2010-11-16

US scientists are significantly more likely to publish fake research than scientists from elsewhere, finds a trawl of officially withdrawn (retracted) studies, published online in the Journal of Medical Ethics. Fraudsters are also more likely to be "repeat offenders," the study shows. The study author searched the PubMed database for every scientific research paper that had been withdrawn—and therefore officially expunged from the public record—between 2000 and 2010. A total of 788 papers had been retracted during this period. Around three quarters of these papers ...

The color of medicine

2010-11-16

According to recent research the color, shape, taste and even name of a tablet or pill can have an effect on how patients feel about their medication. Choose an appropriate combination and the placebo effect gives the pill a boost, improves outcomes and might even reduce side effects. Now, researchers at the University of Bombay, New Mumbai, India, have surveyed users of over-the-counter (OTC) medication to find out just how much the color of a tablet influences patient choice. Writing in the International Journal of Biotechnology, R.K. Srivastava and colleagues report ...

Brain size and a trip to Disneyland

2010-11-16

Evidence from Disneyland suggests that human creativity may have evolved not in response to sexual selection as some scientists believe but as a way to help parents bond with their children and to pass on traditions and cultural knowledge, a new study published in the inaugural issue of the International Journal of Tourism Anthropology suggests. Evolutionary psychologist Geoffrey Miller of the University of New Mexico has suggested that human creativity, storytelling, humor, wit, music, fantasy, and morality, all evolved as forms of courtship behavior. He used evidence ...

New way of predicting dominant seasonal flu strain

2010-11-16

HOUSTON -- (Nov. 15, 2010) -- Rice University scientists have found a way to predict rapidly whether a new strain of the influenza virus should be included in the annual seasonal flu vaccine. While it sometimes takes new flu strains up to three years to become dominant worldwide, the new method can predict whether they will become dominant as little as two weeks after the sequence first appears in the GenBank database, the National Institutes of Health's collection of all publicly available DNA sequences. "We studied a new strain of the virus that evolved in British Columbia ...

Child/teen sexual and physical abuse linked to fibroids in premenopausal women

2010-11-16

(Boston) - Researchers from Boston University School of Medicine (BUSM) have found that both physical and sexual abuse history were positively associated with a higher incidence of uterine fibroids later in life. These findings currently appear on-line in the journal Epidemiology. Uterine leiomyomas, also known as fibroids or myomas, are benign, hormone-dependent tumors that are clinically symptomatic in 20󈞅 percent of reproductive age women. Fibroids contribute to a third of hysterectomies in the US, increase risk of infertility, spontaneous abortion and pelvic ...

Racetrack memory

2010-11-16

Annoyed by how long it took his computer to boot up, Kläui began to think about an alternative. Hard disks are cheap and can store enormous quantities of data, but they are slow; every time a computer boots up, 2-3 minutes are lost while information is transferred from the hard disk into RAM (random access memory). The global cost in terms of lost productivity and energy consumption runs into the hundreds of millions of dollars a day. Like the tried and true VHS videocassette, the proposed solution involves data recorded on magnetic tape. But the similarity ends there; ...

New treatment to overpower drug resistance in ovarian cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: